US Pharma MarketingThe post Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval appeared first on Medical Device Network.
Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval
FDA clearance for Roche’s pTau217 follows the blood-based test’s receipt of a European CE mark in May 2026. The post Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval appeared first on Medical Device Network .
FDA clearance for Roche’s pTau217 follows the blood-based test’s receipt of a European CE mark in May 2026.
Source: Medical Device Network